You are viewing the site in preview mode

Skip to main content

Advertisement

Table 4 Incremental cost-effectiveness ratio per QALY gained

From: Economic evaluation of sildenafil for the treatment of pulmonary arterial hypertension in Indonesia

  FC II FC III
sildenafil vs beraprost sildenafil vs beraprost
Incremental Cost (USD) 1769 4252
Incremental QALYs 0.57 1.50
ICER per QALY gained (USD) 3098 2827